Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Journals
  3. European Psychiatry
  4. Volume 13 Issue s4: standards of psychiatry - 9th congress of associ...
Journal Home
Refine listing

Refine listing

Access:
Publication date:

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

Standards of psychiatry - 9th Congress of Association of European Psychiatrists

Volume 13 - Issue S4 - 1998
Contents

Page 31 of 35

Wed-P40

Symposia

  • P50 in deficit and non deficit schizophrenia

  • S. Louchart, F. Thibaut, D. Levillain, A. van Der Elst, S. Dollfus, M. Petit
  • Published online by Cambridge University Press:
    16 April 2020, p. 300s
    • Article
      • You have access
    • PDF
    • Export citation

Wed-P41

Symposia

Wed-P42

Symposia

  • Influence of severity and duration of psychotic state on the level of middle molecules

  • E. Misionzhnik, A. Molodetskikh, S. Mosolov, M. Uzbekov
  • Published online by Cambridge University Press:
    16 April 2020, p. 300s
    • Article
      • You have access
    • PDF
    • Export citation

Wed-P43

Symposia

Wed-P44

Symposia

Wed-P45

Symposia

Wed-P46

Symposia

  • Pharmacotherapy of anxiety in schizophrenia

  • M. Munjiza, D. Lapčević, N. Ljubomirović, M. Veličković
  • Published online by Cambridge University Press:
    16 April 2020, pp. 301s-302s
    • Article
      • You have access
    • PDF
    • Export citation

Wed-P47

Symposia

Wed-P48

Symposia

Wed-P49

Symposia

  • Ziprasidone: In vivo evidence of central 5HT1A agonist activity

  • H. Rollema, J.S. Sprouse, Y. Lu, L.S. Reynolds, J.P. Braselton, S.H. Zorn
  • Published online by Cambridge University Press:
    16 April 2020, p. 302s
    • Article
      • You have access
    • PDF
    • Export citation

Wed-P50

Symposia

  • Intramuscular (IM) ziprasidone vs. IM haloperidol in patients with acute, non-organic psychosis

  • S. Brook, M. Krams, K. Gunn
  • Published online by Cambridge University Press:
    16 April 2020, p. 303s
    • Article
      • You have access
    • PDF
    • Export citation

Wed-P51

Symposia

Wed-P52

Symposia

Wed-P53

Symposia

  • Intramuscular ziprasidone 10 mg and 20 mg in patients with psychosis and acute agitation

  • K.R Reeves, R.H. Swift, E.P. Harrigan
  • Published online by Cambridge University Press:
    16 April 2020, p. 304s
    • Article
      • You have access
    • PDF
    • Export citation

Wed-P54

Symposia

  • A comparison of intramuscular (IM) ziprasidone with IM haloperidol

  • R.H. Swift, E.P. Harrigan, D.P. van Kammen
  • Published online by Cambridge University Press:
    16 April 2020, p. 304s
    • Article
      • You have access
    • PDF
    • Export citation

Wed-P55

Symposia

Wed-P56

Symposia

Wed-P57

Symposia

  • Impairment of autonomic cardiac vagal function under clozapine

  • M.W. Agelink, R. Malessa, S. Meinecke, T. Zeit, W. Lemmer
  • Published online by Cambridge University Press:
    16 April 2020, p. 305s
    • Article
      • You have access
    • PDF
    • Export citation

Wed-P58

Symposia

  • Clozapine treatment in therapy-refractory schizophrenia: An economic analysis

  • M. Percudani, G. Fattore, J. Galletta, A. Contini, A.C. Altamura
  • Published online by Cambridge University Press:
    16 April 2020, p. 305s
    • Article
      • You have access
    • PDF
    • Export citation

Wed-P5

Symposia

Page 31 of 35